Details der Publikation - A Binding Molecules Able To Neutralize Coronavirus Superfamily

A Binding Molecules Able To Neutralize Coronavirus Superfamily

본 발명은 코로나바이러스 슈퍼패밀리에 중화 활성을 갖는 결합 분자에 관한 것이다. 보다 구체적으로는, 본 발명의 결합 분자는 사스-코로나바이러스-2(SARS-CoV-2) 야생형 및 향후 발생 가능한 변이 바이러스뿐만 아니라, 인간에게 감염되어 치명적인 질병을 유발하는 사스-코로나바이러스(SARS-CoV), 중동호흡기증후군 코로나바이러스 (MERS-CoV) 등을 포함한 인간에게 감염 가능성이 있는 다양한 코로나바이러스 종에 대한 우수한 결합 능력을 가지고, 우수한 중화 효과를 나타내므로, 코로나바이러스로 인하여 발생하는 질환에 대한 진단, 예방 또는 치료에 매우 유용하다..

Medienart:	Patent

Erscheinungsjahr:	2022
Erschienen:	2022

Enthalten in:	Europäisches Patentamt - (2022) vom: 04. Feb. Zur Gesamtaufnahme - year:2022

Sprache:	Koreanisch

Beteiligte Personen:	KIM CHEOL MIN [VerfasserIn] SEO JI MIN [VerfasserIn] AN YONG JIN [VerfasserIn] KIM MIN SOO [VerfasserIn] LEE SOO YOUNG [VerfasserIn] LIM HEE YOUNG [VerfasserIn] LEE JOO YEON [VerfasserIn] KIM KYUNG CHANG [VerfasserIn] YANG JEONG SUN [VerfasserIn] LEE HAN SAEM [VerfasserIn] WOO HYE MIN [VerfasserIn] KIM JUN WON [VerfasserIn]

Links:	Volltext [kostenfrei]

Themen:	615 A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) A61P: Specific therapeutic activity of chemical compounds or medicinal preparations C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) Che G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q) Tec

Anmerkungen:	Source: www.epo.org (no modifications made), First posted: 2022-02-04, Last update posted on www.tib.eu: 2022-08-13, Last updated: 2023-02-09

Patentnummer:	KR20220013302

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	EPA012996610

Internformat


LEADER	01000caa a22002652 4500
001	EPA012996610
003	DE-627
005	20230504121539.0
007	cr uuu---uuuuu
008	230215s2022 xx \|\|\|\|\|o 00\| \|\|kor c
035			\|a (DE-627)EPA012996610
035			\|a (EPA)KR20220013302
035			\|a (EPA)80268238
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a kor
100	0		\|a KIM CHEOL MIN \|e verfasserin \|4 aut
245	1	0	\|a A Binding Molecules Able To Neutralize Coronavirus Superfamily
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a Source: www.epo.org (no modifications made), First posted: 2022-02-04, Last update posted on www.tib.eu: 2022-08-13, Last updated: 2023-02-09
520			\|a 본 발명은 코로나바이러스 슈퍼패밀리에 중화 활성을 갖는 결합 분자에 관한 것이다. 보다 구체적으로는, 본 발명의 결합 분자는 사스-코로나바이러스-2(SARS-CoV-2) 야생형 및 향후 발생 가능한 변이 바이러스뿐만 아니라, 인간에게 감염되어 치명적인 질병을 유발하는 사스-코로나바이러스(SARS-CoV), 중동호흡기증후군 코로나바이러스 (MERS-CoV) 등을 포함한 인간에게 감염 가능성이 있는 다양한 코로나바이러스 종에 대한 우수한 결합 능력을 가지고, 우수한 중화 효과를 나타내므로, 코로나바이러스로 인하여 발생하는 질환에 대한 진단, 예방 또는 치료에 매우 유용하다.
650		4	\|a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
650		4	\|a che
650		4	\|a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
650		4	\|a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
650		4	\|a G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q)
650		4	\|a tec
650		4	\|a 615
700	0		\|a SEO JI MIN \|4 aut
700	0		\|a AN YONG JIN \|4 aut
700	0		\|a KIM MIN SOO \|4 aut
700	0		\|a LEE SOO YOUNG \|4 aut
700	0		\|a LIM HEE YOUNG \|4 aut
700	0		\|a LEE JOO YEON \|4 aut
700	0		\|a KIM KYUNG CHANG \|4 aut
700	0		\|a YANG JEONG SUN \|4 aut
700	0		\|a LEE HAN SAEM \|4 aut
700	0		\|a WOO HYE MIN \|4 aut
700	0		\|a KIM JUN WON \|4 aut
773	0	8	\|i Enthalten in \|t Europäisches Patentamt \|g (2022) vom: 04. Feb.
773	1	8	\|g year:2022 \|g day:04 \|g month:02
856	4	0	\|u https://worldwide.espacenet.com/patent/search/family/80268238/publication/KR20220013302A1?q=KR20220013302 \|z kostenfrei \|3 Volltext
912			\|a GBV_EPA
912			\|a SSG-OLC-PHA
936	u	w	\|j 2022 \|b 04 \|c 02
951			\|a AR
952			\|j 2022 \|b 04 \|c 02

A Binding Molecules Able To Neutralize Coronavirus Superfamily

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände